A Study of Prognostic Factors in Motor Neuron Disease

  • D. Schiffer
  • F. Brignolio
  • A. Chió
  • M. Leone
  • M. G. Rosso
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 209)


Latest advances in the study of motor neuron disease (MND) have pointed out some differences in the course of the illness; subgroups of patients with different survival experience have been identified. A review of studies based on survival analysis is reported in Table 1. It shows the 5-year survival variable from 10 to 50%. Few reports have been devoted to an extensive study of prognostic factors in MND[2, 14, 20, 23]. Age and clinical type at diagnosis are generally considered to influence the course of the disease.


Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis Patient Motor Neuron Disease Motor Neuron Disease Clinical Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. Berkson, Limitations of the application of four-fold table analysis to hospital data, Biometrics Bull., 2: 47–53 (1946).CrossRefGoogle Scholar
  2. 2.
    J. T. Caroscio, W. F. Calhoum, and N. D. Yahr, Prognostic factors in motor neuron disease: a prospective study of longevity, in: F. Clifford Rose, ed., “Research Progress in Motor Neuron Disease,” Pitman, London, pp. 34–43 (1984).Google Scholar
  3. 3.
    A. Chió, F. Brignolio, M. Leone, P. Mortara, M. G. Rosso, A. Tribolo, and D. Schiffer, A survival analysis of 155 cases of progressive muscular atrophy, Acta Neurol.Scand., 72: 401–413 (1985).Google Scholar
  4. 4.
    M. Dalakas, G. Elder, and J. Sever, A 9-year follow-up study of patients with late postpoliomyelitis muscular atrophy (PPMA), Neurology, 35 (1): 108 (1985).CrossRefGoogle Scholar
  5. 5.
    W. D. Dixon, M. B. Brown, L. Engleman, J. W. Frane, M. A. Hill, R. I. Jennrich, and J. D. Toporek, eds., “BMDP Statistical Software,” University of California Press, Los Angeles (1983).Google Scholar
  6. 6.
    L. Forsgren, B. G. L. Almay, G. Holmgren, and S. Wall, Epidemiology of motor neuron disease in Northern Sweden, Acta Neurol.Scand., 68: 20–29 (1983).PubMedCrossRefGoogle Scholar
  7. 7.
    S. Gimenez-Roldán and A. Esteban, Esclerosis lateral amiotrófica familial. Critica de su clasificación y análisis de 14 familias de origen espagnol, Rev.Clin.Esp., 148: 167–173 (1978).PubMedGoogle Scholar
  8. 8.
    L. G. Gunnarsson and R. Palm, Motor neuron disease and heavy manual labor: an epidemiologic survey of Varmland county, Sweden, Neuroepid., 3: 195–206 (1984).CrossRefGoogle Scholar
  9. 9.
    C. H. Hawkes, J. B. Cavanagh, S. Mowbray, and E. A. Paul, Familial motor neuron disease: report of a family with 5 post-mortem studies, in: “Research Progress in Motor Neuron Disease,” F. Clifford Rose, ed., Pitman, London, pp. 70–98 (1984).Google Scholar
  10. 10.
    K. Kondo and I. Hemmi, Clinical statistics in 515 fatal cases of motor neuron disease, Neuroepid., 3: 129–148 (1984).CrossRefGoogle Scholar
  11. 11.
    O. Kristensen and B. Melgaard, Motor neuron disease, Prognosis and epidemiology, Acta Neurol.Scand., 56: 299–308 (1977).PubMedCrossRefGoogle Scholar
  12. 12.
    S. M. Juergens, L. T. Kurland, H. Okazaki, and D. W. Mulder, ALS in Rochester, Minnesota, 1925-1977, Neurology, 30: 463–470 (1980).PubMedCrossRefGoogle Scholar
  13. 13.
    P. Mortara, D. Bardelli, M. Leone, and D. Schiffer, Prognosis and clinical varieties of ALS disease, Ital.J.Neurol.Sei., 2: 237–242 (1981).CrossRefGoogle Scholar
  14. 14.
    P. Mortara, A. Chio, M. G. Rosso, M. Leone, and D. Schiffer, Motor neuron disease in the province of Turin, Italy, 1966-1980, Survival analysis in an unselected population, J.Neurol.Sei., 66: 165–173 (1984).CrossRefGoogle Scholar
  15. 15.
    D. W. Mulder, R. A. Rosenbaum, and D. Layton, Jr., Late progression of poliomyelitis or forme fruste amyotrophic lateral sclerosis? Mayo Clinic Proc., 47: 756–761 (1972).Google Scholar
  16. 16.
    D. W. Mulder and F. M. Howard Jr., Patient resistance and prognosis in amyotrophic lateral sclerosis, Mayo Clinic Proc., 51: 537–541 (1976).Google Scholar
  17. 17.
    K. Murros and R. Fogelholm, Amyotrophic lateral sclerosis in Middle Finland: an epidemiological study, Acta Neurol.Scand., 67: 41–47 (1983).PubMedCrossRefGoogle Scholar
  18. 18.
    F. H. Norris, Adult spinal motor neuron disease, in: “Handbook of Clinical Neurology,” P. J. Vinken and G. W. Bruyn, eds., vol.22, System Disorders and Atrophy, North-Holland, Amsterdam, pp. 1–56.Google Scholar
  19. 19.
    R. Peto, M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, K. MacPherson, J. Peto, and P. G. Smith, Design and analysis of randomized clinical trials requiring prolonged observation of each patient analysis and example, Brit.J.Cancer, 35: 1–39 (1977).PubMedCrossRefGoogle Scholar
  20. 20.
    A. D. Rosen, Amyotrophic lateral sclerosis. Clinical features and prognosis, Arch.Neurol., 35: 638–642 (1978).PubMedCrossRefGoogle Scholar
  21. 21.
    SAS user’s guide: basics, SAS Institute Inc., Cary, N.C. (1982).Google Scholar
  22. 22.
    R. L. Swank and T. J. Putnam, Amyotrophic lateral sclerosis and related conditions. A clinical analysis, Arch.Neurol.Psych., 49: 151–177 (1943).CrossRefGoogle Scholar
  23. 23.
    Y. Uebayashi, Y. Yase, H. Tanaka, Y. Shimada, and Y. Toyokura, Prognosis of motor neuron disease in Japan, Neuroepid., 2: 243–256 (1983).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • D. Schiffer
    • 1
  • F. Brignolio
    • 1
  • A. Chió
    • 1
  • M. Leone
    • 1
  • M. G. Rosso
    • 1
  1. 1.IInd Neurologic ClinicUniversity of TorinoTurinItaly

Personalised recommendations